Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure
FDA adding new Warnings and Precautions to the labels of medicines that contain saxagliptin or alogliptin to inform of the potential increased risk of heart failure.
Source: FDA MedWatch Safety Alert - Category: American Health Source Type: alerts
More News: American Health | Cardiology | Diabetes | Endocrinology | Heart | Heart Failure | Warnings